RhumbLine Advisers
IPSC icon

RhumbLine Advisers’s Century Therapeutics IPSC Stock Holding History

RhumbLine Advisers’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
+128,404
New +$293K ﹤0.01% 3046
2025
Q2 		– Sell
-43,273
Closed -$20.6K – 4198
2025
Q1 		$20.6K Buy
43,273
+182
+0.4% +$137 ﹤0.01% 3733
2024
Q4 		$43.5K Sell
43,091
-6,771
-14% -$9.22K ﹤0.01% 3677
2024
Q3 		$85.3K Sell
49,862
-2,604
-5% -$5.1K ﹤0.01% 3548
2024
Q2 		$134K Buy
52,466
+18,828
+56% +$59.5K ﹤0.01% 3416
2024
Q1 		$141K Buy
33,638
+692
+2% +$2.93K ﹤0.01% 3331
2023
Q4 		$109K Sell
32,946
-1,256
-4% -$2.29K ﹤0.01% 3422
2023
Q3 		$68.4K Buy
34,202
+750
+2% +$2K ﹤0.01% 3576
2023
Q2 		$106K Buy
33,452
+2,350
+8% +$7.58K ﹤0.01% 3508
2023
Q1 		$108K Buy
31,102
+363
+1% +$1.59K ﹤0.01% 2846
2022
Q4 		$158K Buy
30,739
+222
+0.7% +$2.1K ﹤0.01% 2840
2022
Q3 		$302K Buy
30,517
+1,939
+7% +$20.4K ﹤0.01% 2725
2022
Q2 		$240K Buy
28,578
+13,617
+91% +$134K ﹤0.01% 2857
2022
Q1 		$188K Buy
+14,961
New +$198K ﹤0.01% 2772
2021
Q4 		– Sell
-8,697
Closed -$219K – 3009
2021
Q3 		$219K Buy
+8,697
New +$235K ﹤0.01% 2877

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

RhumbLine Advisers's IPSC Position: Q2 2026 in Review

RhumbLine Advisers opened a new position in Century Therapeutics (IPSC) in Q2 2026: 128,404 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #3046 among its holdings. This is a return to the name: RhumbLine Advisers previously reported a position in IPSC as recently as Q1 2025.

RhumbLine Advisers first reported a position in IPSC in Q3 2021 and has held it in 15 quarters since. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • RhumbLine Advisers held 128,404 shares of Century Therapeutics worth $315K as of Q2 2026.
  • Century Therapeutics was a new RhumbLine Advisers position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3046 holding.
  • RhumbLine Advisers first reported a position in Century Therapeutics in Q3 2021 and has held it in 15 quarters since.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.